Connect with us
Biotest, a Grifols group company, expects $1 billion in US sales of its immunoglobulin drug Yimmugo over the next seven years, following FDA approval. Grifols shares...
The process for cannabis clubs permits in Germany could face delays, with a three-month approval period and varying regional regulations. Cultivation associations, legal since July 1,...
A new stacked ETF offers leveraged exposure to both Bitcoin and gold, presenting an intriguing diversification opportunity. This innovative financial product aims to balance the volatility...
Cotton prices rose last week but fell back due to poor export sales and increased planting. USDA reported 11.670 million acres planted, one million more than...
Grifols and PharmaMar significantly dropped Spanish pharmaceutical stocks, with declines of 49.1% and 22.5% respectively in the first half of 2024. Although other companies like Rovi...
Sony, a longtime tech innovator, is launching a cryptocurrency exchange in Japan by acquiring the Amber platform. This move marks a significant entry into the fintech...
Gold creeped slightly higher this past week and the gold stocks also creeped higher. Both, however, are below recent highs but the signs remain positive irrespective...
Next week is a quiet period for the stock market. Since November 20th, the Dow Jones has made 26 new all-time highs, fluctuating between BEV Zero...
Digitalization poses significant challenges for Spanish SMEs, with only 26% adopting cloud technologies compared to 78% of large companies. At the Huawei Cloud Summit Spain 2024,...
Grifols rose almost 3% on the stock market at the start of the trading day this Friday, after the Catalan firm assured that it will be...